Neurological Synergy
Fat loss + GH optimization. AOD-9604 targets lipolysis while CJC-1295 elevates GH for body composition.
AOD-9604 and CJC-1295 (No DAC) work through complementary neurological mechanisms. AOD-9604 (modified c-terminal fragment of human growth hormone that stimulates lipolysis via beta-3 adrenergic receptors without gh side effects.) and CJC-1295 (No DAC) (short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms.) address different aspects of cognitive function, making their combination particularly effective for comprehensive neurological optimization.
Combined Protocol
| Compound | Dose | Frequency | Delivery |
|---|---|---|---|
| AOD-9604 | 300mcg - 500mcg | Daily (fasted) | General |
| CJC-1295 (No DAC) | 100mcg - 200mcg | 2-3x daily (with Ipamorelin) | GH & Cognitive Aging |
Get This Protocol
Alukard provides physician-supervised AOD-9604 + CJC-1295 (No DAC) cognitive protocols with GMP-certified compounds.
Get ProtocolStart Your Cognitive Protocol for AOD-9604 + CJC-1295 (No DAC) Stack
Alukard provides physician-supervised cognitive health protocols with GMP-certified compounds and comprehensive neurological assessments.
HIPAA Compliant · GMP Certified · Physician Supervised